# Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments

> **NCT04893525** · PHASE2,PHASE3 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 658 (estimated)

## Conditions studied

- Opioid-use Disorder

## Interventions

- **DRUG:** Buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT04893525
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-23
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 658 (ESTIMATED)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893525, "Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04893525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*